CIBC Private Wealth Group
GOSS icon

CIBC Private Wealth Group’s Gossamer Bio GOSS Stock Holding History

CIBC Private Wealth Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000
Closed -$986 – 3064
2024
Q3 		$986 Buy
+1,000
New +$962 ﹤0.01% 2911

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

CIBC Private Wealth Group's GOSS Position: Q4 2024 in Review

CIBC Private Wealth Group sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 1,000 shares — an estimated $986 sold.

CIBC Private Wealth Group first reported a position in GOSS in Q3 2024 and held it in 1 quarter. The position peaked at $986 in Q3 2024. 105 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • CIBC Private Wealth Group reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1,000 Gossamer Bio shares in Q4 2024, an estimated $986.
  • CIBC Private Wealth Group first reported a position in Gossamer Bio in Q3 2024 and held it in 1 quarter.
  • CIBC Private Wealth Group's Gossamer Bio position peaked at $986 in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on CIBC Private Wealth Group's 13F filing for Q4 2024, filed 12 Feb 2025.